Atlas Venture closed its ninth venture capital fund at $265 million to finance life science and technology startups.
Across both industries, the VC firm is focused on seed funding for early-stage companies with a typical investment of about...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?